Regeneron Pharmaceuticals Ownership | Who Owns Regeneron Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Regeneron Pharmaceuticals Ownership Summary

Regeneron Pharmaceuticals is owned by 85.76% institutional investors, 1.56% insiders, and 12.68% retail investors. Fmr is the largest institutional shareholder, holding 9.88% of REGN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.12% of its assets in Regeneron Pharmaceuticals shares.

REGN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Regeneron Pharmaceuticals	85.76%	1.56%	12.68%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	10.65M	9.88%	$11.19B
Vanguard group	8.99M	8.34%	$9.45B
Blackrock	8.45M	7.84%	$8.88B
Jpmorgan chase	8.28M	7.68%	$8.70B
State street	4.84M	4.49%	$5.09B
Capital world investors	4.64M	4.30%	$4.88B
Capital investors	3.13M	2.91%	$3.29B
Geode capital management	2.42M	2.24%	$2.53B
Dodge & cox	2.32M	2.15%	$2.43B
Franklin resources	1.92M	1.78%	$2.02B

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Orion investment	29.49K	12.35%	$30.99M
Bronte capital management pty	139.45K	11.47%	$146.57M
Mcdonald capital investors inc/ca	139.20K	9.14%	$146.30M
Rk asset management	9.11K	8.27%	$9.57M
R.p. boggs	8.87K	5.64%	$9.32M
Dcf advisers	10.40K	5.63%	$10.93M
Ellerson group inc /adv	6.99K	5.59%	$7.34M
Healthinvest partners ab	6.89K	4.42%	$7.24M
Krensavage asset management	7.85K	3.79%	$8.25M
Aimz investment advisors	9.98K	3.76%	$10.49M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	1.13M	0.18%	1.13M
Jpmorgan chase	8.28M	0.71%	550.14K
Franklin resources	1.92M	0.62%	228.80K
Capital research global investors	558.79K	0.13%	164.60K
Ubs asset management americas	847.68K	0.26%	163.12K

Top Sellers

Holder	Shares	% Assets	Change
Global assets advisory	-	-	-352.83K
Fmr	10.65M	0.72%	-144.60K
Marshall wace, llp	58.87K	0.08%	-141.51K
Blackrock	8.45M	0.20%	-122.29K
Pictet asset management sa	293.76K	0.35%	-110.48K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.13M	0.18%	1.13M	$1.18B
Mirae asset global etfs	84.38K	0.21%	84.38K	$88.68M
Corebridge financial	37.46K	0.22%	37.46K	$39.38M
Orion investment	29.49K	12.35%	29.49K	$30.99M
Fjarde ap-fonden (the fourth swedish national pensionfund)	29.25K	0.35%	29.25K	$30.75M

Sold Out

Holder	Change
Institutional & family asset management	-1.00
Tfo-tdc	-1.00
Financial gravity asset management	-1.00
Triad wealth partners	-1.00
Impact partnership wealth	-1.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	1,416	2.98%	92,708,421	-1.26%	85	1.14%	652	-1.06%	448	4.92%
Jun 30, 2024	1,358	-0.29%	93,841,367	2.15%	87	1.20%	650	4.67%	422	-5.59%
Mar 31, 2024	1,362	3.34%	91,870,569	0.66%	85	1.16%	621	1.31%	447	0.68%
Dec 31, 2023	1,318	7.15%	91,271,963	0.24%	85	1.17%	613	21.15%	444	0.23%
Sep 30, 2023	1,230	1.49%	91,054,257	-1.44%	85	1.15%	506	4.76%	443	-4.94%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	3.42M	3.12%	-12.23K
Capital Group Growth Fnd of Amer Comp	3.14M	2.84%	-92.79K
American Funds Growth Fund of Amer A	3.14M	2.84%	-92.79K
Vanguard Institutional 500 Index Trust	2.81M	2.56%	33.23K
Fidelity Contrafund	2.67M	2.43%	9.44K
Invesco QQQ Trust	2.10M	1.91%	-9.74K
JPMorgan Large Cap Growth I	1.64M	1.49%	-
Dodge & Cox Stock I	1.56M	1.41%	-
Fidelity 500 Index	1.30M	1.19%	-2.23K
American Funds New Perspective A	1.30M	1.18%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 01, 2024	McCourt Marion	EVP Commercial	Sell	$844.61K
Oct 01, 2024	RYAN ARTHUR F	-	Sell	$5.22K
Oct 01, 2024	RYAN ARTHUR F	-	Sell	$9.40K
Oct 01, 2024	RYAN ARTHUR F	-	Sell	$7.32K
Oct 01, 2024	RYAN ARTHUR F	-	Sell	$1.04K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	19
2024 Q3	-	117
2024 Q2	-	113
2024 Q1	-	116
2023 Q4	-	60

REGN Ownership FAQ

Who Owns Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals shareholders are primarily institutional investors at 85.76%, followed by 1.56% insiders and 12.68% retail investors. The average institutional ownership in Regeneron Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Regeneron Pharmaceuticals exceeds.

Who owns the most shares of Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals’s largest shareholders are Fmr (10.65M shares, 9.88%), Vanguard group (8.99M shares, 8.34%), and Blackrock (8.45M shares, 7.84%). Together, they hold 26.06% of Regeneron Pharmaceuticals’s total shares outstanding.

Does Blackrock own Regeneron Pharmaceuticals?

Yes, BlackRock owns 7.84% of Regeneron Pharmaceuticals, totaling 8.45M shares as of Jun 2024. This represents 0.20% of BlackRock's total assets, with a market value of 8.88B$. In the last quarter, BlackRock decreased its holdings by -122K shares, a -1.43% change.

Who is Regeneron Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Orion investment is Regeneron Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 12.35% of its assets in 29.49K Regeneron Pharmaceuticals shares, valued at 30.99M$.

Who is the top mutual fund holder of Regeneron Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Regeneron Pharmaceuticals shares, with 3.12% of its total shares outstanding invested in 3.42M Regeneron Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools